Alain Bernard, PhD

General Manager at BPAC, formerly VectivBio

Speaker

Dr. Alain Bernard is the founder and general manager of BAPC, a strategic biopharma consultancy, and brings more than 35 years of experience in bioprocess development and manufacturing. He was Chief Technology Officer of the biotech startup company VectivBio, when it was acquired by Ironwood Pharma mid-2023. Prior to joining VectivBio, Dr Bernard served as Head of Global Biotech Process Development at R-Pharm and Vice-President of Biopharmaceutical Process Sciences at UCB. During the 10 years spent at UCB, he oversaw process development for all new chemical and biological entities. He contributed to launching several biotech and small molecules into commercial phases and lifecycle management of marketed products. Prior to UCB, Dr. Bernard served as Director of Biotech Process Development at Merck Serono where he was responsible for the biotechnology process developments that delivered several improved processes for biotech products. He began his career at Biogen Geneva, a site that was transitioned to the Glaxo-Wellcome Institute of Molecular Biology

Dr Bernard earned his Ph.D. in Biochemical Engineering from a joint program between AgroParisTech in France and the MIT in the US.